Skip to main content
Erschienen in: The Indian Journal of Pediatrics 2/2017

27.10.2016 | Clinical Brief

I Cell Disease (Mucolipidosis II Alpha/Beta): From Screening to Molecular Diagnosis

verfasst von: Ankur Singh, Rajniti Prasad, Aditya Kumar Gupta, Anil Sharma, Sandra Alves, Maria Francisca Coutinho, Seema Kapoor, Om Prakash Mishra

Erschienen in: Indian Journal of Pediatrics | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Mucopolysaccharidosis (MPS) and Mucolipidosis (ML) share common phenotypes (coarse facial features, organomegaly, dysostosis multiplex) despite having different molecular basis. Thus, they pose great diagnostic challenge to treating clinicians. Differentiating between the two conditions requires a battery of tests from screening to molecular diagnosis. Besides discussing differential diagnosis of MPS like features with negative urinary Glycosaminoglycans (GAG), the authors also discuss the utility of p-nitrocatechol sulphate based chemical test as an important screening tool, besides establishing molecular basis in index case.
Literatur
1.
Zurück zum Zitat Tiede S, Storch S, Lübke T, et al. Mucolipidosis II is caused by mutations in GNPTA encoding the alpha/beta GlcNAc-1-phosphotransferase. Nat Med. 2005;11:1109–12.CrossRefPubMed Tiede S, Storch S, Lübke T, et al. Mucolipidosis II is caused by mutations in GNPTA encoding the alpha/beta GlcNAc-1-phosphotransferase. Nat Med. 2005;11:1109–12.CrossRefPubMed
2.
Zurück zum Zitat Paik KH, Song SM, Ki CS, et al. Identification of mutations in the GNPTA (MGC4170) gene coding for GlcNAc-phosphotransferase alpha/beta subunits in Korean patients with mucolipidosis type II or type IIIA. Hum Mutat. 2005;26:308–14.CrossRefPubMed Paik KH, Song SM, Ki CS, et al. Identification of mutations in the GNPTA (MGC4170) gene coding for GlcNAc-phosphotransferase alpha/beta subunits in Korean patients with mucolipidosis type II or type IIIA. Hum Mutat. 2005;26:308–14.CrossRefPubMed
3.
Zurück zum Zitat Sheth J, Mistri M, Kamate M, et al. Diagnostic strategy for mucolipidosis II/III. Indian Pediatr. 2012;49:975–7.CrossRefPubMed Sheth J, Mistri M, Kamate M, et al. Diagnostic strategy for mucolipidosis II/III. Indian Pediatr. 2012;49:975–7.CrossRefPubMed
4.
Zurück zum Zitat Fuller M, Tucker JN, Lang DL, et al. Screening patients referred to a metabolic clinic for lysosomal storage disorders. J Med Genet. 2011;48:422–5.CrossRefPubMed Fuller M, Tucker JN, Lang DL, et al. Screening patients referred to a metabolic clinic for lysosomal storage disorders. J Med Genet. 2011;48:422–5.CrossRefPubMed
5.
Zurück zum Zitat Cury GK, Matte U, Artigalás O, et al. Mucolipidosis II and III alpha/beta in Brazil: analysis of the GNPTAB gene. Gene. 2013;524:59–64.CrossRefPubMed Cury GK, Matte U, Artigalás O, et al. Mucolipidosis II and III alpha/beta in Brazil: analysis of the GNPTAB gene. Gene. 2013;524:59–64.CrossRefPubMed
6.
Zurück zum Zitat Aggarwal S, Coutinho MF, Dalal AB, Mohamed Nurul Jain SJ, Prata, MJ, Alves S. Prenatal skeletal dysplasia phenotype in severe MLII alpha/beta with novel GNPTAB mutation. Gene. 2014;542:266–8. Aggarwal S, Coutinho MF, Dalal AB, Mohamed Nurul Jain SJ, Prata, MJ, Alves S. Prenatal skeletal dysplasia phenotype in severe MLII alpha/beta with novel GNPTAB mutation. Gene. 2014;542:266–8.
7.
Zurück zum Zitat Encarnação M, Lacerda L, Costa R, et al. Molecular analysis of the GNPTAB and GNPTG genes in 13 patients with mucolipidosis type II or type III - identification of eight novel mutations. Clin Genet. 2009;76:76–84.CrossRefPubMed Encarnação M, Lacerda L, Costa R, et al. Molecular analysis of the GNPTAB and GNPTG genes in 13 patients with mucolipidosis type II or type III - identification of eight novel mutations. Clin Genet. 2009;76:76–84.CrossRefPubMed
8.
Zurück zum Zitat Coutinho MF, Santos Lda S, Girisha KM, et al. Mucolipidosis type II α/β with a homozygous missense mutation in the GNPTAB gene. Am J Med Genet A. 2012;158A:1225–8.CrossRefPubMed Coutinho MF, Santos Lda S, Girisha KM, et al. Mucolipidosis type II α/β with a homozygous missense mutation in the GNPTAB gene. Am J Med Genet A. 2012;158A:1225–8.CrossRefPubMed
9.
Zurück zum Zitat Nampoothiri S, Yesodharan D, Sainulabdin G, et al. Eight years experience from a skeletal dysplasia referral center in a tertiary hospital in southern India: a model for the diagnosis and treatment of rare diseases in a developing country. Am J Med Genet A. 2014;164A:2317–23.CrossRefPubMed Nampoothiri S, Yesodharan D, Sainulabdin G, et al. Eight years experience from a skeletal dysplasia referral center in a tertiary hospital in southern India: a model for the diagnosis and treatment of rare diseases in a developing country. Am J Med Genet A. 2014;164A:2317–23.CrossRefPubMed
Metadaten
Titel
I Cell Disease (Mucolipidosis II Alpha/Beta): From Screening to Molecular Diagnosis
verfasst von
Ankur Singh
Rajniti Prasad
Aditya Kumar Gupta
Anil Sharma
Sandra Alves
Maria Francisca Coutinho
Seema Kapoor
Om Prakash Mishra
Publikationsdatum
27.10.2016
Verlag
Springer India
Erschienen in
Indian Journal of Pediatrics / Ausgabe 2/2017
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-016-2243-7

Weitere Artikel der Ausgabe 2/2017

The Indian Journal of Pediatrics 2/2017 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.